 NexImmune Inc NASDAQ: NEXI and Zephyr AI have announced a strategic partnership focusing on discovering and validating novel targets for new T-cell-mediated therapies in oncology. The collaboration will combine Zephyrs artificial intelligence and algorithmic. 